Please enable JavaScript to continue using this application.

Compare $IBRX vs $PCVX | Chartloom

Compare

$IBRX vs $PCVX

Immunitybio Inc · Vaxcyte Inc

IBRX

Immunitybio Inc

PCVX

Vaxcyte Inc

Compare $IBRX vs $PCVX

Comparing Immunitybio Inc and Vaxcyte Inc

IBRXImmunitybio Inc

PCVXVaxcyte Inc

IBRXImmunitybio Inc

Market cap

$11.01B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

40.40x

Rev growth (TTM)

192.9%

YTD performance

420.3%

52W performance

315.4%

FCF yield

-2.6%

PCVXVaxcyte Inc

Market cap

$10.31B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

53.6%

52W performance

75.2%

FCF yield

-8.9%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

IBRX

PCVX

Detailed metrics comparison

IBRX

Immunitybio Inc

PCVX

Vaxcyte Inc

Market Cap

IBRX$11.01B

PCVX$10.31B

Enterprise Value

IBRX$12.12B

PCVX$10.12B

Price

IBRX$10.51

PCVX$71.38

P/E Ratio

IBRXN/A

PCVXN/A

P/S Ratio

IBRX66.39x

PCVX0.00x

EV/Sales

IBRX73.11x

PCVX0.00x

EV/EBITDA

IBRX0.00x

PCVX0.00x

P/B Ratio

IBRX73.35x

PCVX3.05x

P/FCF Ratio

IBRXN/A

PCVXN/A

EV/FCF

IBRX-42.01x

PCVX-10.99x

PEG Ratio

IBRXN/A

PCVXN/A

Forward P/E (NTM)

IBRXN/A

PCVXN/A

Forward P/S (NTM)

IBRX40.40x

PCVXN/A

Revenue (TTM)

IBRX$166M

PCVX$0

Revenue Growth (YoY)

IBRX192.9%

PCVXN/A

Forward Rev Growth

IBRX111.5%

PCVX157.2%

Gross Margin (TTM)

IBRX99.3%

PCVX0.0%

Operating Margin (TTM)

IBRX0.0%

PCVX0.0%

EBITDA Margin (TTM)

IBRX-141.9%

PCVX0.0%

Net Margin (TTM)

IBRX-598.6%

PCVX0.0%

FCF Margin (TTM)

IBRX-174.0%

PCVXN/A

Net Income (TTM)

IBRX$-992M

PCVX$-1.06B

FCF (TTM)

IBRX$-289M

PCVX$-921M

EPS (TTM)

IBRX-$0.95

PCVX-$7.37

ROE (TTM)

IBRX-19329.0%

PCVX-3757.0%

ROA (TTM)

IBRX-17288.0%

PCVX-3362.0%

ROIC (TTM)

IBRX-19300.0%

PCVX-3757.0%

Cash

IBRX$76M

PCVX$183M

Debt

IBRX$1.19B

PCVX$0

Net Cash/Debt

IBRX$-1.11B

PCVX$183M

Current Ratio (TTM)

IBRX5.72x

PCVX5.72x

Quick Ratio (TTM)

IBRX5.36x

PCVX5.48x

Debt/Equity (TTM)

IBRX0.01x

PCVX0.00x

Debt/Assets (TTM)

IBRX0.0%

PCVX0.0%

Interest Coverage (TTM)

IBRXN/A

PCVXN/A

Net Debt/EBITDA (TTM)

IBRX0.00x

PCVX0.00x

Beta

IBRX0.17

PCVX1.31

52W Performance

IBRX315.4%

PCVX75.2%

YTD Performance

IBRX420.3%

PCVX53.6%

% from 52W High

IBRX-15.4%

PCVX-21.3%

% from 52W Low

IBRX439.0%

PCVX79.0%

Asset Turnover (TTM)

IBRX0.29x

PCVX0.00x

FCF Yield (TTM)

IBRX-2.6%

PCVX-8.9%

Earnings Yield (TTM)

IBRX-9.0%

PCVX-10.3%

Dividend Yield (TTM)

IBRXN/A

PCVXN/A

Rule of 40

IBRX18.9

PCVX0.0

EV/GP/RG

IBRX1.12

PCVXN/A

Ticker research

View IBRX research View PCVX research

Metric	IBRX Immunitybio Inc	PCVX Vaxcyte Inc
Market & Valuation
Market Cap	$11.01B	$10.31B
Enterprise Value	$12.12B	$10.12B
Price	$10.51	$71.38
P/E Ratio	N/A	N/A
P/S Ratio	66.39x	0.00x
EV/Sales	73.11x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	73.35x	3.05x
P/FCF Ratio	N/A	N/A
EV/FCF	-42.01x	-10.99x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	40.40x	N/A
Revenue & Growth
Revenue (TTM)	$166M	$0
Revenue Growth (YoY)	192.9%	N/A
Forward Rev Growth	111.5%	157.2%
Profitability
Gross Margin (TTM)	99.3%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-141.9%	0.0%
Net Margin (TTM)	-598.6%	0.0%
FCF Margin (TTM)	-174.0%	N/A
Net Income (TTM)	$-992M	$-1.06B
FCF (TTM)	$-289M	$-921M
EPS (TTM)	-$0.95	-$7.37
ROE (TTM)	-19329.0%	-3757.0%
ROA (TTM)	-17288.0%	-3362.0%
ROIC (TTM)	-19300.0%	-3757.0%
Financial Health
Cash	$76M	$183M
Debt	$1.19B	$0
Net Cash/Debt	$-1.11B	$183M
Current Ratio (TTM)	5.72x	5.72x
Quick Ratio (TTM)	5.36x	5.48x
Debt/Equity (TTM)	0.01x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.17	1.31
52W Performance	315.4%	75.2%
YTD Performance	420.3%	53.6%
% from 52W High	-15.4%	-21.3%
% from 52W Low	439.0%	79.0%
Efficiency & Yields
Asset Turnover (TTM)	0.29x	0.00x
FCF Yield (TTM)	-2.6%	-8.9%
Earnings Yield (TTM)	-9.0%	-10.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	18.9	0.0
EV/GP/RG	1.12	N/A
Ticker research	View IBRX research	View PCVX research

Valuation

P/S Ratio

PCVX

0.00x

IBRX

66.39x

EV/FCF

IBRX

-42.01x

PCVX

-10.99x

Growth & revenue

Revenue Growth TTM

IBRX

192.9%

Forward Revenue Growth

PCVX

157.2%

IBRX

111.5%

Profitability & performance

Gross Margin

IBRX

99.3%

PCVX

0.0%

ROE

PCVX

-3757.0%

IBRX

-19329.0%

FCF Yield %

IBRX

-2.6%

PCVX

-8.9%

52-Week Performance

IBRX

315.4%

PCVX

75.2%

Detailed metrics comparison

IBRX

Immunitybio Inc

PCVX

Vaxcyte Inc

Market Cap

IBRX$11.01B

PCVX$10.31B

Enterprise Value

IBRX$12.12B

PCVX$10.12B

Price

IBRX$10.51

PCVX$71.38

P/E Ratio

IBRXN/A

PCVXN/A

P/S Ratio

IBRX66.39x

PCVX0.00x

EV/Sales

IBRX73.11x

PCVX0.00x

EV/EBITDA

IBRX0.00x

PCVX0.00x

P/B Ratio

IBRX73.35x

PCVX3.05x

P/FCF Ratio

IBRXN/A

PCVXN/A

EV/FCF

IBRX-42.01x

PCVX-10.99x

PEG Ratio

IBRXN/A

PCVXN/A

Forward P/E (NTM)

IBRXN/A

PCVXN/A

Forward P/S (NTM)

IBRX40.40x

PCVXN/A

Revenue (TTM)

IBRX$166M

PCVX$0

Revenue Growth (YoY)

IBRX192.9%

PCVXN/A

Forward Rev Growth

IBRX111.5%

PCVX157.2%

Gross Margin (TTM)

IBRX99.3%

PCVX0.0%

Operating Margin (TTM)

IBRX0.0%

PCVX0.0%

EBITDA Margin (TTM)

IBRX-141.9%

PCVX0.0%

Net Margin (TTM)

IBRX-598.6%

PCVX0.0%

FCF Margin (TTM)

IBRX-174.0%

PCVXN/A

Net Income (TTM)

IBRX$-992M

PCVX$-1.06B

FCF (TTM)

IBRX$-289M

PCVX$-921M

EPS (TTM)

IBRX-$0.95

PCVX-$7.37

ROE (TTM)

IBRX-19329.0%

PCVX-3757.0%

ROA (TTM)

IBRX-17288.0%

PCVX-3362.0%

ROIC (TTM)

IBRX-19300.0%

PCVX-3757.0%

Cash

IBRX$76M

PCVX$183M

Debt

IBRX$1.19B

PCVX$0

Net Cash/Debt

IBRX$-1.11B

PCVX$183M

Current Ratio (TTM)

IBRX5.72x

PCVX5.72x

Quick Ratio (TTM)

IBRX5.36x

PCVX5.48x

Debt/Equity (TTM)

IBRX0.01x

PCVX0.00x

Debt/Assets (TTM)

IBRX0.0%

PCVX0.0%

Interest Coverage (TTM)

IBRXN/A

PCVXN/A

Net Debt/EBITDA (TTM)

IBRX0.00x

PCVX0.00x

Beta

IBRX0.17

PCVX1.31

52W Performance

IBRX315.4%

PCVX75.2%

YTD Performance

IBRX420.3%

PCVX53.6%

% from 52W High

IBRX-15.4%

PCVX-21.3%

% from 52W Low

IBRX439.0%

PCVX79.0%

Asset Turnover (TTM)

IBRX0.29x

PCVX0.00x

FCF Yield (TTM)

IBRX-2.6%

PCVX-8.9%

Earnings Yield (TTM)

IBRX-9.0%

PCVX-10.3%

Dividend Yield (TTM)

IBRXN/A

PCVXN/A

Rule of 40

IBRX18.9

PCVX0.0

EV/GP/RG

IBRX1.12

PCVXN/A

Ticker research

View IBRX research View PCVX research

Metric	IBRX Immunitybio Inc	PCVX Vaxcyte Inc
Market & Valuation
Market Cap	$11.01B	$10.31B
Enterprise Value	$12.12B	$10.12B
Price	$10.51	$71.38
P/E Ratio	N/A	N/A
P/S Ratio	66.39x	0.00x
EV/Sales	73.11x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	73.35x	3.05x
P/FCF Ratio	N/A	N/A
EV/FCF	-42.01x	-10.99x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	40.40x	N/A
Revenue & Growth
Revenue (TTM)	$166M	$0
Revenue Growth (YoY)	192.9%	N/A
Forward Rev Growth	111.5%	157.2%
Profitability
Gross Margin (TTM)	99.3%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-141.9%	0.0%
Net Margin (TTM)	-598.6%	0.0%
FCF Margin (TTM)	-174.0%	N/A
Net Income (TTM)	$-992M	$-1.06B
FCF (TTM)	$-289M	$-921M
EPS (TTM)	-$0.95	-$7.37
ROE (TTM)	-19329.0%	-3757.0%
ROA (TTM)	-17288.0%	-3362.0%
ROIC (TTM)	-19300.0%	-3757.0%
Financial Health
Cash	$76M	$183M
Debt	$1.19B	$0
Net Cash/Debt	$-1.11B	$183M
Current Ratio (TTM)	5.72x	5.72x
Quick Ratio (TTM)	5.36x	5.48x
Debt/Equity (TTM)	0.01x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.17	1.31
52W Performance	315.4%	75.2%
YTD Performance	420.3%	53.6%
% from 52W High	-15.4%	-21.3%
% from 52W Low	439.0%	79.0%
Efficiency & Yields
Asset Turnover (TTM)	0.29x	0.00x
FCF Yield (TTM)	-2.6%	-8.9%
Earnings Yield (TTM)	-9.0%	-10.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	18.9	0.0
EV/GP/RG	1.12	N/A
Ticker research	View IBRX research	View PCVX research